Development and validation of novel inflammatory response-related gene signature to predict prostate cancer recurrence and response to immune checkpoint therapy
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP389104
下载链接
链接失效反馈官方服务：
资源简介：
The aim of this study is to construct an inflammatory response-related genes (IRRGs) signature to monitor biochemical recurrence (BCR) and treatment effects in prostate cancer patients (PCa) Overall design: We applied RNA-seq to screen out the differentially expressed genes (DEGs) between the benign prostate cell line and the PCa cell line, including 4 of BPH-1, 4 of DU145, and 4 of PC3
创建时间：
2022-10-28
